Loading…
First successful treatment of Nocardia farcinica brain abscess with moxifloxacin
Nocardia farcinica is an emerging pathogen in immunosuppressed patients causing both localized and disseminated infections. Many strains of this species are multidrug-resistant and require long-term antibiotic therapy, and consequently the choice of an oral treatment can be problematic. We report he...
Saved in:
| Published in: | The Journal of infection 2006-04, Vol.52 (4), p.e99-e102 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3 |
| container_end_page | e102 |
| container_issue | 4 |
| container_start_page | e99 |
| container_title | The Journal of infection |
| container_volume | 52 |
| creator | Fihman, Vincent Berçot, Béatrice Mateo, Joaquim Losser, Marie-Reine Raskine, Laurent Riahi, Jacques Loirat, Philippe Pors, Marie-José Sanson-Le |
| description | Nocardia farcinica is an emerging pathogen in immunosuppressed patients causing both localized and disseminated infections. Many strains of this species are multidrug-resistant and require long-term antibiotic therapy, and consequently the choice of an oral treatment can be problematic. We report here the first case of successful treatment of
N. farcinica brain abscess in a renal transplant recipient with an extended-spectrum fluoroquinolone, moxifloxacin. |
| doi_str_mv | 10.1016/j.jinf.2005.08.001 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67819986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445305002288</els_id><sourcerecordid>67819986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3</originalsourceid><addsrcrecordid>eNqNkTtPwzAUhS0EouXxBxiQJ7YEO44dR2JBFS-pAobulmNfC1d5FDuB8u9J1EpswHSX7xxdnQ-hC0pSSqi4Xqdr37o0I4SnRKaE0AM0p5xlSVbk2SGajxBL8pyzGTqJcU0IKVkpjtGMCiqpkHSOXu99iD2OgzEQoxtq3AfQfQNtjzuHnzujg_UaOx2Mb73RuArat1hXcQrgT9-_4abbeld3Wz0iZ-jI6TrC-f6eotX93WrxmCxfHp4Wt8vEMEb7pKq0hVJWznDB8syCtFxmAjhwxzhY7iqrmSx4RipSCmFpWQhRAJSMa-HYKbra1W5C9z5A7FXjx4_qWrfQDVGJQtKylOJPkBaUT7P8ByR5XhQjmO1AE7oYAzi1Cb7R4UtRoiYxaq0mMWoSo4hUo5gxdLlvH6oG7E9kb2IEbnYAjKN9eAgqGg-tAesDmF7Zzv_W_w30BJ--</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17104477</pqid></control><display><type>article</type><title>First successful treatment of Nocardia farcinica brain abscess with moxifloxacin</title><source>ScienceDirect Journals</source><creator>Fihman, Vincent ; Berçot, Béatrice ; Mateo, Joaquim ; Losser, Marie-Reine ; Raskine, Laurent ; Riahi, Jacques ; Loirat, Philippe ; Pors, Marie-José Sanson-Le</creator><creatorcontrib>Fihman, Vincent ; Berçot, Béatrice ; Mateo, Joaquim ; Losser, Marie-Reine ; Raskine, Laurent ; Riahi, Jacques ; Loirat, Philippe ; Pors, Marie-José Sanson-Le</creatorcontrib><description>Nocardia farcinica is an emerging pathogen in immunosuppressed patients causing both localized and disseminated infections. Many strains of this species are multidrug-resistant and require long-term antibiotic therapy, and consequently the choice of an oral treatment can be problematic. We report here the first case of successful treatment of
N. farcinica brain abscess in a renal transplant recipient with an extended-spectrum fluoroquinolone, moxifloxacin.</description><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2005.08.001</identifier><identifier>PMID: 16181681</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>16S rRNA gene ; Anti-Infective Agents - therapeutic use ; Aza Compounds - therapeutic use ; Biopsy, Needle ; Brain abscess ; Brain Abscess - drug therapy ; Fluoroquinolones ; Humans ; Immunocompromised Host ; Immunosuppressive Agents - administration & dosage ; Kidney Transplantation - immunology ; Lung Abscess - pathology ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Moxifloxacin ; Nocardia - isolation & purification ; Nocardia farcinica ; Nocardia Infections - drug therapy ; Organs transplant recipient ; Quinolines - therapeutic use ; RNA, Ribosomal, 16S - genetics ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>The Journal of infection, 2006-04, Vol.52 (4), p.e99-e102</ispartof><rights>2005 The British Infection Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3</citedby><cites>FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16181681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fihman, Vincent</creatorcontrib><creatorcontrib>Berçot, Béatrice</creatorcontrib><creatorcontrib>Mateo, Joaquim</creatorcontrib><creatorcontrib>Losser, Marie-Reine</creatorcontrib><creatorcontrib>Raskine, Laurent</creatorcontrib><creatorcontrib>Riahi, Jacques</creatorcontrib><creatorcontrib>Loirat, Philippe</creatorcontrib><creatorcontrib>Pors, Marie-José Sanson-Le</creatorcontrib><title>First successful treatment of Nocardia farcinica brain abscess with moxifloxacin</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><description>Nocardia farcinica is an emerging pathogen in immunosuppressed patients causing both localized and disseminated infections. Many strains of this species are multidrug-resistant and require long-term antibiotic therapy, and consequently the choice of an oral treatment can be problematic. We report here the first case of successful treatment of
N. farcinica brain abscess in a renal transplant recipient with an extended-spectrum fluoroquinolone, moxifloxacin.</description><subject>16S rRNA gene</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Aza Compounds - therapeutic use</subject><subject>Biopsy, Needle</subject><subject>Brain abscess</subject><subject>Brain Abscess - drug therapy</subject><subject>Fluoroquinolones</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Kidney Transplantation - immunology</subject><subject>Lung Abscess - pathology</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Moxifloxacin</subject><subject>Nocardia - isolation & purification</subject><subject>Nocardia farcinica</subject><subject>Nocardia Infections - drug therapy</subject><subject>Organs transplant recipient</subject><subject>Quinolines - therapeutic use</subject><subject>RNA, Ribosomal, 16S - genetics</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkTtPwzAUhS0EouXxBxiQJ7YEO44dR2JBFS-pAobulmNfC1d5FDuB8u9J1EpswHSX7xxdnQ-hC0pSSqi4Xqdr37o0I4SnRKaE0AM0p5xlSVbk2SGajxBL8pyzGTqJcU0IKVkpjtGMCiqpkHSOXu99iD2OgzEQoxtq3AfQfQNtjzuHnzujg_UaOx2Mb73RuArat1hXcQrgT9-_4abbeld3Wz0iZ-jI6TrC-f6eotX93WrxmCxfHp4Wt8vEMEb7pKq0hVJWznDB8syCtFxmAjhwxzhY7iqrmSx4RipSCmFpWQhRAJSMa-HYKbra1W5C9z5A7FXjx4_qWrfQDVGJQtKylOJPkBaUT7P8ByR5XhQjmO1AE7oYAzi1Cb7R4UtRoiYxaq0mMWoSo4hUo5gxdLlvH6oG7E9kb2IEbnYAjKN9eAgqGg-tAesDmF7Zzv_W_w30BJ--</recordid><startdate>200604</startdate><enddate>200604</enddate><creator>Fihman, Vincent</creator><creator>Berçot, Béatrice</creator><creator>Mateo, Joaquim</creator><creator>Losser, Marie-Reine</creator><creator>Raskine, Laurent</creator><creator>Riahi, Jacques</creator><creator>Loirat, Philippe</creator><creator>Pors, Marie-José Sanson-Le</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200604</creationdate><title>First successful treatment of Nocardia farcinica brain abscess with moxifloxacin</title><author>Fihman, Vincent ; Berçot, Béatrice ; Mateo, Joaquim ; Losser, Marie-Reine ; Raskine, Laurent ; Riahi, Jacques ; Loirat, Philippe ; Pors, Marie-José Sanson-Le</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>16S rRNA gene</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Aza Compounds - therapeutic use</topic><topic>Biopsy, Needle</topic><topic>Brain abscess</topic><topic>Brain Abscess - drug therapy</topic><topic>Fluoroquinolones</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Kidney Transplantation - immunology</topic><topic>Lung Abscess - pathology</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Moxifloxacin</topic><topic>Nocardia - isolation & purification</topic><topic>Nocardia farcinica</topic><topic>Nocardia Infections - drug therapy</topic><topic>Organs transplant recipient</topic><topic>Quinolines - therapeutic use</topic><topic>RNA, Ribosomal, 16S - genetics</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fihman, Vincent</creatorcontrib><creatorcontrib>Berçot, Béatrice</creatorcontrib><creatorcontrib>Mateo, Joaquim</creatorcontrib><creatorcontrib>Losser, Marie-Reine</creatorcontrib><creatorcontrib>Raskine, Laurent</creatorcontrib><creatorcontrib>Riahi, Jacques</creatorcontrib><creatorcontrib>Loirat, Philippe</creatorcontrib><creatorcontrib>Pors, Marie-José Sanson-Le</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fihman, Vincent</au><au>Berçot, Béatrice</au><au>Mateo, Joaquim</au><au>Losser, Marie-Reine</au><au>Raskine, Laurent</au><au>Riahi, Jacques</au><au>Loirat, Philippe</au><au>Pors, Marie-José Sanson-Le</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First successful treatment of Nocardia farcinica brain abscess with moxifloxacin</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2006-04</date><risdate>2006</risdate><volume>52</volume><issue>4</issue><spage>e99</spage><epage>e102</epage><pages>e99-e102</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><abstract>Nocardia farcinica is an emerging pathogen in immunosuppressed patients causing both localized and disseminated infections. Many strains of this species are multidrug-resistant and require long-term antibiotic therapy, and consequently the choice of an oral treatment can be problematic. We report here the first case of successful treatment of
N. farcinica brain abscess in a renal transplant recipient with an extended-spectrum fluoroquinolone, moxifloxacin.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>16181681</pmid><doi>10.1016/j.jinf.2005.08.001</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0163-4453 |
| ispartof | The Journal of infection, 2006-04, Vol.52 (4), p.e99-e102 |
| issn | 0163-4453 1532-2742 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67819986 |
| source | ScienceDirect Journals |
| subjects | 16S rRNA gene Anti-Infective Agents - therapeutic use Aza Compounds - therapeutic use Biopsy, Needle Brain abscess Brain Abscess - drug therapy Fluoroquinolones Humans Immunocompromised Host Immunosuppressive Agents - administration & dosage Kidney Transplantation - immunology Lung Abscess - pathology Male Microbial Sensitivity Tests Middle Aged Moxifloxacin Nocardia - isolation & purification Nocardia farcinica Nocardia Infections - drug therapy Organs transplant recipient Quinolines - therapeutic use RNA, Ribosomal, 16S - genetics Tomography, X-Ray Computed Treatment Outcome |
| title | First successful treatment of Nocardia farcinica brain abscess with moxifloxacin |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A16%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20successful%20treatment%20of%20Nocardia%20farcinica%20brain%20abscess%20with%20moxifloxacin&rft.jtitle=The%20Journal%20of%20infection&rft.au=Fihman,%20Vincent&rft.date=2006-04&rft.volume=52&rft.issue=4&rft.spage=e99&rft.epage=e102&rft.pages=e99-e102&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2005.08.001&rft_dat=%3Cproquest_cross%3E67819986%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c331t-bbade98bfc56342de8d5826e5e5f35ed5fbda387520b0966d197667ee935a6f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17104477&rft_id=info:pmid/16181681&rfr_iscdi=true |